These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7739269)

  • 21. Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
    Klepin HD; Hurd DD
    Bone Marrow Transplant; 2006 Nov; 38(9):585-92. PubMed ID: 16953209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disease-specific survival for patients with multiple myeloma: significant improvements over time in all age groups.
    Libby E; Garcia D; Quintana D; Fekrazad MH; Bauman J; Ebaid A; Hromas R; Rabinowitz I; Wiggins C
    Leuk Lymphoma; 2014 Dec; 55(12):2850-7. PubMed ID: 24588734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitality index in survival modeling: how physiological aging influences mortality.
    Zuev SM; Yashin AI; Manton KG; Dowd E; Pogojev IB; Usmanov RN
    J Gerontol A Biol Sci Med Sci; 2000 Jan; 55(1):B10-9. PubMed ID: 10719758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changing demographics and neurologic disease in the elderly.
    Riggs JE
    Neurol Clin; 1996 May; 14(2):477-86. PubMed ID: 8827184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing trends of multiple myeloma mortality in England and Wales; 1950-79: are the changes real?
    Velez R; Beral V; Cuzick J
    J Natl Cancer Inst; 1982 Aug; 69(2):387-92. PubMed ID: 6955544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
    Milano AF
    J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma.
    Veltri LW; Milton DR; Delgado R; Shah N; Patel K; Nieto Y; Kebriaei P; Popat UR; Parmar S; Oran B; Ciurea S; Hosing C; Lee HC; Manasanch E; Orlowski RZ; Shpall EJ; Champlin RE; Qazilbash MH; Bashir Q
    Cancer; 2017 Sep; 123(18):3568-3575. PubMed ID: 28513828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ESRD due to Multiple Myeloma in the United States, 2001-2010.
    Reule S; Sexton DJ; Solid CA; Chen SC; Foley RN
    J Am Soc Nephrol; 2016 May; 27(5):1487-94. PubMed ID: 26516209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinogenesis, genetic instability and genomic entropy: insight derived from malignant brain tumor age specific mortality rate dynamics.
    Riggs JE
    J Theor Biol; 1994 Oct; 170(4):331-8. PubMed ID: 7996860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential survival and natural selection: their impact upon aging and cancer mortality.
    Riggs JE
    Mech Ageing Dev; 1996 Dec; 92(2-3):111-20. PubMed ID: 9080392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rising ovarian cancer mortality in the elderly: a manifestation of differential survival.
    Riggs JE
    Gynecol Oncol; 1995 Jul; 58(1):64-7. PubMed ID: 7789892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival of elderly patients with multiple myeloma-Effect of upfront autologous stem cell transplantation.
    Merz M; Jansen L; Castro FA; Hillengass J; Salwender H; Weisel K; Scheid C; Luttmann S; Emrich K; Holleczek B; Katalinic A; Nennecke A; Straka C; Langer C; Engelhardt M; Einsele H; Kröger N; Beelen D; Dreger P; Brenner H; Goldschmidt H;
    Eur J Cancer; 2016 Jul; 62():1-8. PubMed ID: 27185572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mortality trends in multiple myeloma after the introduction of novel therapies in the United States.
    Binder M; Nandakumar B; Rajkumar SV; Kapoor P; Buadi FK; Dingli D; Lacy MQ; Gertz MA; Hayman SR; Leung N; Fonder A; Hobbs M; Hwa YL; Muchtar E; Warsame R; Kourelis TV; Gonsalves WI; Russell S; Lin Y; Siddiqui M; Kyle RA; Dispenzieri A; Kumar SK
    Leukemia; 2022 Mar; 36(3):801-808. PubMed ID: 34702976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epidemiology of multiple myeloma.
    Riedel DA; Pottern LM
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):225-47. PubMed ID: 1582971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple myeloma and benzene exposure in a multinational cohort of more than 250,000 petroleum workers.
    Wong O; Raabe GK
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):188-99. PubMed ID: 9356282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aging: damage accumulation versus increasing mortality rate.
    Finkelstein M
    Math Biosci; 2007 May; 207(1):104-12. PubMed ID: 17112546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of multiple myeloma in Olmsted County, Minnesota: 1978 through 1990, with a review of the trend since 1945.
    Kyle RA; Beard CM; O'Fallon WM; Kurland LT
    J Clin Oncol; 1994 Aug; 12(8):1577-83. PubMed ID: 8040670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using the Gompertz-Strehler model of aging and mortality to explain mortality trends in industrialized countries.
    Riggs JE; Millecchia RJ
    Mech Ageing Dev; 1992 Sep; 65(2-3):217-28. PubMed ID: 1434950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple myeloma in north east Scotland: a review of incidence and survival over three decades.
    Soutar RL; Dawson AA; Wilson BJ
    Health Bull (Edinb); 1996 May; 54(3):232-40. PubMed ID: 8707567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of vulnerability measures and their effect on survival in a real-life population of multiple myeloma patients registered at Marche Region Multiple Myeloma Registry.
    Offidani M; Corvatta L; Polloni C; Centurioni R; Visani G; Brunori M; Gentili S; Catarini M; Samori A; Blasi N; Alesiani F; Caraffa P; Burattini M; Galieni P; Fraticelli P; Ferranti M; Giuliodori L; Leoni P
    Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):423-32. PubMed ID: 22981966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.